AOD-9604 is a fragment of the human growth hormone developed for the treatment of obesity. It is designed to mimic the fat-burning properties of hGH without its muscle-building effects or the common side effects.
This is achieved through Tyrosine (TYR), a portion of the amino acid sequence responsible for fat reduction and tissue repair. It mimics the effects of hGH on lipid metabolism without promoting growth or triggering pro-diabetic effects.
Where GLP-1 agonists suppress appetite and influence insulin secretion, AOD-9604 inhibits lipoprotein lipase activity in fat tissue, stimulating lipolysis in adipocytes. It specifically targets areas of the body with high fat deposits, preventing the conversion of carbohydrates into triglycerides and fatty acids and blocking the process of lipogenesis.
AOD-9604 can be particularly useful when stacked with GLP-1s to combat plateaus and target stubborn fat that diet and exercise alone may not eliminate.
AOD-9604 is a fragment of the human growth hormone developed for the treatment of obesity. It is designed to mimic the fat-burning properties of hGH without its muscle-building effects or the common side effects.
This is achieved through Tyrosine (TYR), a portion of the amino acid sequence responsible for fat reduction and tissue repair. It mimics the effects of hGH on lipid metabolism without promoting growth or triggering pro-diabetic effects.
Where GLP-1 agonists suppress appetite and influence insulin secretion, AOD-9604 inhibits lipoprotein lipase activity in fat tissue, stimulating lipolysis in adipocytes. It specifically targets areas of the body with high fat deposits, preventing the conversion of carbohydrates into triglycerides and fatty acids and blocking the process of lipogenesis.
AOD-9604 can be particularly useful when stacked with GLP-1s to combat plateaus and target stubborn fat that diet and exercise alone may not eliminate.